
OUR HISTORY
- 2022: Launch of the new warehouse extention after two years of building.
- 2021:
- Eumedica’s 35 year anniversary
- Creation of our UK entity, Eumedica Pharma Ltd
- Construction of a new warehouse on our site Eumedica Nauwelette
- Conclusion of an exclusive distribution agreement of the Temgesic® outside North America
- Acquisition of a 1000m² warehouse, Eumedica Scailmont
- 2020: Launch of Temocillin (Temopen®) in Germany
- 2019: Start of the worldwide distribution of Bactrim®
- 2018: A third of the top ten pharmaceutical multinationals selects Eumedica for the distribution of their clinical trial products worldwide
- 2016: Eumedica’s 30 year anniversary
- 2015: Launch of Negaban® in France
- 2014: Increase of our storage capacities (up to 10,000 m²)
- 2013: Distribution of the antipsychotics product range (Dipiperon®, Orap®, Imap®, Impromen Decanoas® and Impromen®)
- 2012: Extension of our logistics centre
- 2009: Distribution of Somatostatine-Eumedica® worldwide
- 2007: Another of the top ten pharmaceutical multinationals trusts Eumedica for the distribution of their clinical trial products worldwide except US and South America
- 2006: Launch of Negaban® in the United Kingdom
- 2006: Launch of Somatostatine-Belpharma® in Belgium
- 2004: Launch of Actosolv® in France
- 2003: Eumedica moves to its new distribution centre in Manage
- 2002: Expansion of Eumedica’s product portfolio with: Dopram®, Robinul® and Robinul Neostigmine®, Actosolv®
- 2002: One of the largest pharmaceutical multinationals chooses Eumedica to distribute their clinical trial products worldwide
- 1998: Distribution of Negaban® (Temocillin)
- 1986: Creation